ClinicalTrials.Veeva

Menu

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

Boehringer Ingelheim logo

Boehringer Ingelheim

Status and phase

Completed
Phase 3
Phase 2

Conditions

Bladder, Neurogenic

Treatments

Drug: Placebo
Drug: tamsulosin hydrochloride

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

Aim of this study is to evaluate the efficacy and safety of a range of doses of tamsulosin hydrochloride as treatment in children with an elevated detrusor leak point pressure associated with a known neurological deficit

Enrollment

231 patients

Sex

All

Ages

2 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Neuropathic bladder secondary to a known neurologic deficit (e.g. spina bifida)
  • Elevated detrusor leak point pressures (LPP) ≥40 cm H2O confirmed by two measurements

Exclusion criteria

  • Clinically significant abnormalities as determined by the investigator
  • A history of relevant orthostatic hypotension, fainting spells or blackouts

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

231 participants in 4 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Participants received matching placebo to tamsulosin hydrochloride via opened capsules every day for 14 weeks
Treatment:
Drug: Placebo
Low dose
Experimental group
Description:
Participants received 0.001 - 0.002 mg/kg tamsulosin hydrochloride via opened capsules every day for 14 weeks
Treatment:
Drug: tamsulosin hydrochloride
Medium dose
Experimental group
Description:
Participants received 0.002 - 0.004 mg/kg tamsulosin hydrochloride via opened capsules every day for 14 weeks
Treatment:
Drug: tamsulosin hydrochloride
High dose
Experimental group
Description:
Participants received 0.004 - 0.008 mg/kg tamsulosin hydrochloride via opened capsules every day for 14 weeks
Treatment:
Drug: tamsulosin hydrochloride

Trial contacts and locations

52

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems